Wednesday, Jul 23

New Study Published in Acta Phlebologica

Michael Arata MD of Synergy Health Concepts published the results of a new study into the safety and effectiveness of the TVAM procedure in patients with autonomic dysfunction, including patients with multiple sclerosis and other chronic conditions. The study was published in the April 2014 edition of Acta Phlebologica: A Journal on Phlebology.

Transvascular autonomic modulation (TVAM) is a novel treatment that may provide relief for those suffering from symptoms of sympathetic autonomic dysfunction, including fatigue, brain fog and heat intolerance. Autonomic dysfunction is often present in patients with chronic conditions such as fibromyalgia, multiple sclerosis and chronic fatigue syndrome and might be responsible for many of the most disabling symptoms experienced by these patients.

This new study finds that the TVAM treatment is not only safe but also quite often effective in improving symptoms. Read more about the study here.

To learn more about TVAM treatment for patients with MS, visit this page.

If you have any questions or would like to learn more, feel free to give us a call at 877-792-2784, and we will get back to you promptly to answer any questions you might have. Alternately, you can contact us via our web form.



Powered by Facebook Comments

Written by